[PDF][PDF] Safe management of 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX)+ panitumumab in a patient with metastatic colorectal cancer undergoing hemodialysis …
E Filoni, V Musci, G Dibisceglia, F Mannavola - 2023 - cdn.amegroups.cn
Background: Chemotherapy in metastatic colorectal cancer (mCRC) undergoing in
hemodialysis (HD) for end-stage renal disease (ESRD) remains an unsolved problem due to …
hemodialysis (HD) for end-stage renal disease (ESRD) remains an unsolved problem due to …
[引用][C] Safe management of 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX)+ panitumumab in a patient with metastatic colorectal cancer undergoing hemodialysis …
E Filoni, V Musci, G Dibisceglia… - Precision Cancer …, 2023 - pcm.amegroups.org
Safe management of 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) + panitumumab in a
patient with metastatic colorectal cancer undergoing hemodialysis for bilateral nephrectomy: a …
patient with metastatic colorectal cancer undergoing hemodialysis for bilateral nephrectomy: a …